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TonEBP regulates 
the hyperosmotic expression 
of aquaporin 1 and 5 
in the intervertebral disc
J. W. Snuggs1, S. Tessier2, R. A. B. Bunning1, I. M. Shapiro2,3, M. V. Risbud2,3 & 
C. L. Le Maitre1*
The central region of the intervertebral disc (IVD) is rich in proteoglycans, leading to a hyperosmotic 
environment, which fluctuates with daily loading. The cells of the nucleus pulposus (NP cells) have 
adapted to this environment via the function of tonicity enhancer binding protein (TonEBP), and 
NP cells have been shown to express several water channels known as aquaporins (AQP). We have 
previously shown that AQP1 and 5 decrease during IVD degeneration. Here, the regulation of AQP1 
and 5 by hyperosmotic conditions and the role of TonEBP in this regulation was investigated. AQP1 
and 5 gene expression was upregulated by hyperosmotic conditions mimicking the osmolality 
of the healthy IVD, which was abrogated by TonEBP knockdown. Furthermore, AQP1 and 5 
immunopositivity was significantly reduced in  TonEBPΔ/Δ E17.5 mice when compared with wildtype 
controls, indicating in vivo expression of AQP1 and 5 is controlled at least in part by TonEBP. This 
hyperosmotic regulation of AQP1 and 5 could help to explain the decreased AQP1 and 5 expression 
during degeneration, when the osmolality of the NP decreases. Together this data suggests that 
TonEBP-regulated osmo-adaptation may be disrupted during IVD degeneration when the expression 
of both AQPs is reduced.
Many factors contribute to the function of the nucleus pulposus (NP). The environment in which NP cells reside 
plays a role in the physiology of the tissue; biomechanical loading, pH, nutrition,  O2 tension and adaptation 
to a diurnal cycle all allow NP tissues to function  correctly1–5. High content of negatively charged, hydrophilic 
glycosaminoglycans (GAGs) within the NP matrix allows water and cation retention and provides a high osmotic 
pressure environment within the  disc1,6,7. This physiologically hyperosmotic environment has been shown to 
stimulate matrix  synthesis6,8,9, providing evidence that NP cells have adapted to the higher osmolality and hydro-
static pressure imposed on them by the NP tissue environment. However, osmotic stress (both hyper- and hypo-) 
is known to cause many disruptions to cellular activity such as elevation of reactive oxygen species, cytoskeletal 
rearrangement, inhibition of transcription and translation, damage to DNA and proteins and eventually cell 
 death10. Thus, it is important to understand how NP cells have been able to adapt to this constantly changing 
hyperosmotic environment.
Whilst there are many cell signalling pathways activated during osmotic stress, the role of tonicity enhancer 
binding protein (TonEBP) (also known as nuclear factor of activated T-cells 5; NFAT5) is argubly the most well-
known11. Within many tissues TonEBP enables adaptation to a hyperosmotic environment. Whilst the exact 
mechanisms by which cells sense osmotic shifts is unknown, studies suggest that integrins α6β412 and α1β113, a 
guanine nucleotide exchange factor,  Brx14, and biomechanical  stretching15 may all activate TonEBP signalling. 
When cells are exposed to hyperosmotic stimuli, TonEBP is translocated into the nucleus. In the nucleus it forms 
homodimers and binds to tonicity response elements (TonE) on target genes, via rel homology domains, causing 
their  upregulation16. These well-described target genes include sodium/myo-inositol transporters (SMIT), aldose 
reductase (AR), betaine-GABA transporter 1 (BGT1), heat shock protein-70 (HSP-70) and taurine transporter 
(TauT), that all facilitate the exchange of charged ions within cells for small non-ionic  osmolytes7,10,16,17. Thus, 
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the osmotic pressure across the cell membrane can be restored and cellular adaptation to the hyperosmotic 
extracellular environment enabled.
TonEBP has an emerging role in the function of the IVD and similar tissues. Under hyperosmotic conditions 
TonEBP regulates the expression of osmotic response  genes18,19, aggrecan  expression18 and key enzyme Beta-
1,3-Glucuronyltransferase 3 (β3gat3) involved in synthesis of chondroitin and heparan sulphate  sidechains20 in 
NP cells. More recently the function of TonEBP has been shown to be vital during fundamental processes within 
the spine, as TonEBP deficiency caused delayed notochord and IVD  embryogenesis21 and an acceleration of 
age-related IVD degeneration in  mice22. Whilst in the chondrogenic ATDC5 cell line, TonEBP is involved in the 
hyperosmotic induction of sox9, collagen II and X, Runx2 and  aggrecan23. As TonEBP allows NP cells to adapt to 
their hyperosmotic surroundings, regulate the matrix composition and osmotic status of the NP, it is important 
to determine what other pathways are potentially regulated by TonEBP to enable the correct function of the IVD.
As the IVD experiences fluctuations in the local osmolality there are potentially many proteins and mecha-
nisms that contribute to the osmoadaptation of the resident  cells24. One such family of proteins that may con-
tribute are aquaporins (AQP). AQPs are transmembrane channel proteins responsible for the rapid, selective 
movement of water and other small molecules. These channels contribute to many cellular processes such as cell 
volume  regulation25, cell structure and  adhesion26, cell migration and  proliferation27 and the overall maintenance 
of water homeostasis within many  tissues28.
Many AQPs are expressed within NP  tissue29–31. Their presence suggests that water transport is tightly con-
trolled and very important for NP cell functionality. The basal expression levels of AQP1 and 5 in NP cells 
is regulated by HIF-1α30, which does not explain why the expression of both AQPs is decreased during IVD 
 degeneration30; therefore, other degenerative changes may be implicated in the dysregulation of AQP1 and 5. 
AQP expression has been shown to be regulated by alterations in extracellular osmolality in many  tissues32–38. 
However, only one study to date has investigated this within the context of IVD, demonstrating that TonEBP 
controlled AQP2 expression under hyperosmotic  conditions39.
Within other cells/tissues, AQP1 expression is upregulated by hyperosmolality in mIMCD-3 kidney  cells32–34 
and mouse cardiac endothelial  cells35. AQP5 expression has also been shown to be upregulated by hyperosmolal-
ity in 3AO ovarian cancer  cells36, rat alveolar epithelial  cells37 and human retinal epithelial  cells38, in which AQP5 
expression was reduced after hypo-osmotic  treatment38. TonEBP has also been implicated with the hyperosmotic 
upregulation of both  AQP133,34 and  AQP538. This potentially indicates that both AQPs are also regulated in the 
same manner in NP cells, as the osmolality of NP tissue decreases during degeneration. There is also a precedence 
of AQP regulation in the IVD; AQP3 expression was upregulated by hyperosmolality in murine notochordal 
(NC)  cells40 and the hyperosmotic upregulation of AQP2 in rodent NP cells was dependent on  TonEBP39. If 
AQP1 and 5 are regulated in this manner, it may implicate them in enabling the adaptation of NP cells to their 
hyperosmotic environment along with other TonEBP target genes. This adaptation may be diminished during 
degeneration when their expression is reduced, possibly by the lowered extracellular osmolality.
This study investigated the potential regulation of AQP1 and 5 expression under osmotic conditions rep-
resentative of the normal and degenerative IVD to identify potential mechanisms that may account for the 
decreased expression of AQP1 and 5 observed during disc  degeneration30. Furthermore, the role of TonEBP in 
the regulation of AQP expression was investigated in IVD cells.
Results
Hyperosmotic regulation of AQP1 and 5 gene expression in human NP cells. AQP1 gene expres-
sion was significantly upregulated in 2D monolayer cultured human NP cells after 24 h (p = 0.046) and 72 h 
(p = 0.005) hyperosmotic treatment (425  mOsm/kg) when compared to untreated controls (325  mOsm/kg) 
(Fig. 1a). The gene expression of AQP5 in 2D monolayer cultured human NP cells was upregulated by the same 
hyperosmotic treatment at 12 (p = 0.04), 24 (p = 0.0041), 48 (p = 0.0146) and 72 h (p = 0.0342), when compared 
with untreated controls (Fig. 1b). During 3D alginate culture of human NP cells, which restores the in vivo 
phenotype, AQP1 gene expression was upregulated by 48 h of 425 mOsm/kg (p ≤ 0.0366) and 525 mOsm/kg 
(p = 0.0407) treatment compared to 325 mOsm/kg controls (Fig. 1c), whereas AQP5 expression was only upreg-
ulated by 425 mOsm/kg treatment for 48 h, compared to untreated controls (p ≤ 0.0271) (Fig. 1d).
Hyperosmotic regulation of AQP1 and 5 gene expression in rat NP cells. AQP1 protein in rat NP 
cells cultured in monolayer was observed by immunofluorescence staining (Fig. 2a). AQP1 gene expression was 
significantly upregulated in rat NP cells after 8 h treatment with 425 mOsm/kg media (p = 0.04) and after 8 h 
(p = 0.021) and 24 h (p = 0.03) treatment with 525 mOsm/kg media (Fig. 2b). After 8 h of 525 mOsm/kg media 
treatment AQP1 gene expression was significantly higher compared to cells exposed to the same treatment for 
24 h (p = 0.04) (Fig. 2b). Treatment with 425 mOsm/kg media failed to significantly regulate AQP1 gene expres-
sion (Fig. 2b). AQP5 protein in rat NP cells in monolayer was assessed by immunofluorescence staining (Fig. 2c). 
AQP5 gene expression was significantly upregulated in rat NP cells following 8 h (p = 0.025) and 24 h (p = 0.04) 
treatment with 525 mOsm/kg media (Fig. 2c). Similar to AQP1 gene regulation, AQP5 gene expression was 
significantly increased after 8 h of 525 mOsm/kg treatment when compared to 24 h of the same treatment in rat 
NP cells (p = 0.033) (Fig. 2d).
The effect of TonEBP knockdown on the hyperosmotic regulation of AQP1 and 5 in rat NP 
cells. In rat NP cells transduced with shTonEBP lentiviral vector the gene expression of TonEBP was signifi-
cantly reduced compared to TonEBP expression in rat NP cells transduced with shCTR (p < 0.0001) (Fig. 3a). In 
shCTR cells, TonEBP gene expression was significantly upregulated in cells treated with 525 mOsm/kg media 
when compared with untreated controls (325 mOsm/kg) (p = 0.021) (Fig. 3a). These results highlight that TonEBP 
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is functional within shCTR cells and expression is successfully knocked down in shTonEBP cells. AQP1 gene 
expression was upregulated when rat NP cells were treated for 24 h with hyperosmotic media (525 mOsm/kg) 
in shCTR NP cells (p ≤ 0.021) (Fig. 3b). When TonEBP expression was knocked down, AQP1 gene expression in 
both untreated (p < 0.0001) and hyperosmotic (p = 0.0003) treatment groups was significantly reduced compared 
to shCTR controls (Fig. 3b). AQP5 gene expression was still upregulated when rat NP cells were treated for 24 h 
with hyperosmotic media (525 mOsm/kg) in shCTR NP cells (p = 0.0361) (Fig. 3b). When TonEBP expression 
was knocked down, AQP5 gene expression in both untreated (p = 0.007) and hyperosmotic (p = 0.038) treatment 
groups were significantly reduced when compared to the same treatment in shCTR cells (Fig. 3c).
Effect of TonEBP expression on the in vivo expression of AQP1 and 5. To determine whether 
AQP1 and AQP5 levels are responsive to TonEBP in  vivo, we analysed AQP1 and 5 abundance in discs of 
TonEBP −/− mice. Since null mice show high perinatal lethality, we chose to stain discs of E17.5 animals. The 
percentage area of AQP1 fluorescent staining within the NP region of TonEBP −/− mice (Δ/Δ) was significantly 
Figure 1.  Hyperosmotic regulation of AQP1 and 5 gene expression in human NP cells. Regulation of (a) AQP1 
and (b) AQP5 gene expression, after 8—72 h treatment with 425 mOsm/kg media, in human NP cells cultured 
in monolayer up to passage 2 prior to treatment. Regulation of (c) AQP1 and (d) AQP5 gene expression, after 
48 h treatment with 425 or 525 mOsm/kg media, in human NP cells cultured for 2w encapsulated in alginate 
beads prior to treatment. The osmolality of untreated controls in standard culture media was 325 mOsm/kg. 
The osmolality of treatment media was altered using NaCl and was measured using a freezing point depression 
osmometer (Model 3320 osmometer, Advanced Instruments). Human NP cells from 3 patients in technical 
triplicates were utilised for gene expression experiments. Statistical significance determined using Kruskal–
Wallis test * = p ≤ 0.05.
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Figure 2.  Hyperosmotic localisation of (a) AQP1 and (b) AQP5 in monolayer cultured rat NP cells. Gene 
regulation of (c) AQP1 and (d) AQP5 under hyperosmotic conditions. (e) Rabbit IgG isotype control. Scale bar 
20 µM. Three repeats using pooled NP cells from 3 rats were utilised for gene expression experiments. Statistical 
significance determined using Kruskal–Wallis test * = p ≤ 0.05.
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Figure 3.  The effects of TonEBP knockdown on the hyperosmotic regulation of AQP1 and 5 in rat NP cells. Rat 
NP cells were exposed to control (325 mOsm/kg) or hyperosmotic (525 mOsm/kg) treatment for 24 hr, after 4d 
of TonEBP knockdown (shTonEBP) or no knockdown control (shCTR). After knockdown and treatment, the 
gene expression of TonEBP (a), AQP1 (b) and AQP5 (c) was determined, respectively. Results were normalised 
to 325 mOsm/kg shCTR controls. Three repeats using pooled NP cells from 3 rats were utilised for gene 
expression experiments. Statistical significance determined using Kruskal–Wallis test * = p ≤ 0.05.
6
Vol:.(1234567890)
Scientific Reports |         (2021) 11:3164  | https://doi.org/10.1038/s41598-021-81838-9
www.nature.com/scientificreports/
reduced compared to AQP1 staining area within the NP region of wildtype (WT) mice (p = 0.0007) (Fig. 4a–e). 
The percentage of AQP5 fluorescent staining within the NP region of TonEBP −/− mice (Δ/Δ) was also signifi-
cantly reduced compared to AQP5 staining within the NP region of wildtype (WT) mice (p < 0.0001) (Fig. 4d–j).
Figure 4.  The in vivo expression of AQP1 & 5 in wildtype and TonEBP knockout mice embryos. Fluorescent 
IHC images showing AQP1 (a) and AQP5 (f) staining (red) in wildtype (WT) 17.E mouse spines. Increased 
magnification highlights the localisation of AQP1 (b) and AQP5 (g) within the nucleus pulposus (NP) region. 
Fluorescent IHC images showing AQP1 (c) and AQP5 (h) staining (red) in TonEBP knockout (Δ/Δ) 17.E 
mouse spines. Increased magnification highlights the localisation of AQP1 (d) and AQP5 (i) within the nucleus 
pulposus (NP) region of Δ/Δ mice. Quantification of the percentage NP area containing AQP1 (e) and AQP5 
(j) staining in WT and Δ/Δ mice. The median values of each cohort are represented by the horizontal line in 
each column. Annulus fibrosus (AF) and vertebral body (VB) regions are depicted (white dashed lines; a,c,f,h). 
Cell nuclei counterstained with DAPI (blue). Scale bar (a,c,f,h) = 100 µm. Scale bar (b,d,g,i) = 50 µm. Five WT 
and five Δ/Δ mouse embryos were used for IHC staining, with at least three representative discs per embryo. 
Statistical significance determined using Kruskal–Wallis test * = p ≤ 0.05.
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Discussion
NP cells have adapted to the environment in which they reside. The physiological  O2  tension41,  pH42, nutrient 
 diffusion2, mechanical  loading8 and  osmolality9 of the healthy disc allows NP cells to function correctly. When 
the IVD undergoes degeneration, this environment is altered, exacerbating cellular dysfunction. Previous stud-
ies have identified that many AQPs are expressed by NP  tissue29,30,31,39,43,44. However, only a few studies identify 
how the expression of AQPs is regulated in the disc. AQP1 and 5 expression are decreased during human IVD 
 degeneration30, yet the cause of this, and how both AQPs are regulated in the NP, is unknown. Therefore, for the 
first time to our knowledge this study has identified that AQP1 and 5 gene expression in NP cells is upregulated 
by hyperosmolality representative of the normal IVD environment. This could explain why their expression 
decreases during IVD degeneration, as the osmolality of the NP decreases. This study also determined that the 
in vitro and in vivo expression of AQP1 and 5 expression in NP cells is TonEBP dependent. As TonEBP is an 
important transcription factor involved in the overall function of the IVD, the regulation of AQPs by TonEBP 
may implicate that their function is also important for the health of the IVD.
AQP1 and 5 in human and rat NP cells were upregulated in hyperosmotic conditions that mimic the physi-
ological conditions of the healthy IVD. AQP1 and 5 are also regulated in a similar manner, under similar 
hyperosmotic conditions, in a range of other tissues and cell  types32–38, possibly indicating shared mechanisms 
of regulation. However, hyperosmotic treatment has also led to the reduction of AQP1 and 5 expression in the 
murine choroid  plexus45 and hypo-osmotic treatment has led to increased expression of AQP1 in nasal  glands46, 
highlighting that the osmotic regulation of AQP expression is also tissue and cell type-specific. 3D hyperosmotic 
treatment of human NP cells also showed upregulation of AQP1 and 5, along with 2D treatment, indicating that 
this response was physiologically relevant, as NP cells are known to re-differentiate into an in vivo-like state 
when cultured in 3D.
AQP1 and 5 gene expression in human NP cells was upregulated by hyperosmotic conditions with an osmo-
lality of 425 mOsm/kg, yet the highest upregulation of AQP1 and 5 gene expression in rat NP cells was observed 
with 525 mOsm/kg treatment. This potentially indicates that there are differences in regulation across species 
or with age, possibly due to the differences in NP environments and osmotic baselines between adult human 
and young rat discs. The differences in gene expression may also be a result of the treatment timeframe. AQP1 
expression in rat NP cells is significantly upregulated after 8 h treatment, yet after 24 h there is no significant 
difference compared to baseline levels, and AQP5 was not upregulated at either time point. This may simply be 
due to AQP regulation by 425mOs/kg occurring before 8 h or after 24 h.
Nevertheless, AQP1 and 5 are regulated by osmolality in a similar manner in human and rodent NP cells. This 
potentially indicates that osmotic AQP expression is regulated by shared mechanisms and that AQP regulation 
is important for IVD function across species. Therefore, transitioning to investigate the role of TonEBP on the 
hyperosmotic regulation of AQP1 and 5 in rats (in vitro) and mice (in vivo), may also reveal the function of 
TonEBP on such regulation in humans. AQP1 and 5 may enable NP cells to adapt to their hyperosmolar envi-
ronment, and when expression decreases in  degeneration30 this may be due to the decrease in the extracellular 
osmolality, causing further dysfunction of NP cells. This may suggest that AQP1 and 5 expression is decreased, 
as a consequence of initial degeneration, but also leads to a continuation of the degenerative cascade where 
cells can no longer adapt to their environment. TonEBP is critical in enabling cells to adapt to a hyperosmotic 
environment, which is essential for NP cells, as they reside within a hyperosmotic environment during healthy 
IVD physiology.
This study identified that AQP1 and 5 gene expression, along with their hyperosmotic upregulation, in rat 
NP cells was significantly reduced when TonEBP expression was knocked down. These results highlight that 
AQP1 and 5 expression in NP cells is potentially governed by the expression and function of TonEBP. TonEBP 
has also been shown to regulate the expression of AQP1 and 5 in other  tissues33,34,38, providing a precedent for 
results observed in this study. TonEBP expression is also required for the hyperosmotic upregulation of AQP2 
in NP  cells39, therefore AQP1, 2 and 5 may enable the adaptation of NP cells to their hyperosmolar environment 
along with the classical TonEBP-targeted osmotic response genes.
Along with the classical function in regulating the cell’s response to hyperosmotic stress, TonEBP has also 
been shown to increase the expression of TNF-α47, IL-648 and MCP-148,49 under hyperosmotic conditions, all of 
which are upregulated in IVD  degeneration50–52. Parallel to the role under hyperosmotic stress, TonEBP is also 
activated by TNF-α signalling in NP cells, which leads to the upregulation of genes involved in IVD degeneration, 
rather than the classical osmotic response  genes53.This highlights that TonEBP may also play a role during IVD 
degeneration; under hypo-osmotic conditions TonEBP no longer upregulates osmotic response genes, possibly 
including AQP1, 2 and 5, but rather is activated by TNF-α signalling, intensifying the degenerative  cascade53.
AQP expression and function has also been implicated in enabling cells to sense osmotic stress via membrane 
tension  changes54, interactions with other osmotically activated membrane  channels55,56, and the control of cell 
volume  regulation25, indicating that AQPs may also function upstream of TonEBP to enable cellular adaptation 
to osmolality changes. It is currently unknown if AQP1 and 5 could function upstream of TonEBP, where AQPs 
at the membrane could potentially contribute to sensing changes in membrane tension, via modulating the flow 
of water in response to changes in  osmolality54. Activated TonEBP could then consequently upregulate AQP1 
and 5 further, forming a positive feedback loop ensuring adaptation to the extracellular environment. However, 
this hypothesis is speculative at present and requires further study. As TonEBP also regulates the expression of 
NP matrix genes, if AQP1 and 5 expression in NP cells is linked to TonEBP, they may also be linked to matrix 
production and therefore the fundamental function of NP cells to maintain the integrity of the IVD.
NP expression of AQP1 and 5 was higher in the spines of WT mice compared to TonEBP −/− mice. This 
suggests that in vivo expression of AQP1 and 5 in the IVD is reliant upon TonEBP expression, strengthening 
the in vitro regulation also identified in this study. Unfortunately, the in vivo expression of AQP1 and 5 was only 
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able to be investigated during embryonic development due to the lethality of the TonEBP knockdown. Results 
highlight that during development TonEBP is essential for the maintenance of AQP1 and 5 expression within the 
NP. However, it is still unknown if TonEBP contributes to in vivo AQP expression in the adult, where many other 
factors (altered compared to the embryonic environment) could contribute to the physiology of mature NP cells, 
when compared to the physiology of notochordal cells; the abundant cell type of the NP during development.
Conclusion
We have previously shown that AQP1 and 5 expression is decreased during human IVD  degeneration30. This 
study has identified that AQP1 and 5 are upregulated by hyperosmolality, mimicking the healthy NP, and may 
explain why expression is decreased during degeneration, when the osmolality is decreased. This suggests AQP1 
and 5 may be part of the mechanisms that allow NP cells to adapt to their hyperosmotic environment. TonEBP is 
an essential transcription factor which enables osmoadaptation, the finding here that the hyperosmotic upregula-
tion of AQP1 and 5 is dependent on TonEBP, implies they both participate in the osmoadaptation process and 
potential downstream effects on matrix synthesis. During IVD degeneration TonEBP function is uncoupled from 
the altered osmolality and catabolic genes are upregulated instead of the classical osmotic response genes. As 
expression of these genes (and AQP1 and 5) is reduced, NP cells can no longer adapt to the degenerate environ-
ment and degeneration is exacerbated. Therefore, AQPs may play a role in adapting NP cells to their environment 
and maintaining the function of NP tissue.
Materials and methods
Experimental design. To explore the potential mechanisms for the previously identified decrease in AQP1 
and 5 expression in NP tissue during IVD  degeneration30, AQP1 and 5 expression was determined in human NP 
cells under osmotic conditions representative of physiological healthy to degenerate IVD. Human NP cells were 
investigated in 2D (monolayer) and 3D (alginate) culture to determine whether monolayer culture could be used 
as a model system for osmotic responses, enabling facile manipulation of conditions for future studies. Gene 
regulation of AQP1 and 5 was investigated in 2D cultured rat NP cells, to determine if responses to hyperosmo-
lality were similar across species as knockdown in vitro studies are optimised for rat cells. Subsequently, TonEBP 
was knocked down in rat NP cells prior to the application of hyperosmotic stimuli to determine if TonEBP 
controlled the hyperosmotic regulation of AQP1 and 5 gene expression. To investigate if TonEBP regulated 
in vivo expression of AQP1 and 5, IHC was performed on the IVDs of WT and TonEBP −/− mouse embryos. All 
methods were carried out in accordance with relevant guidelines and regulations. Ethical approval was granted 
from Sheffield Research Ethics Committee (09/H1308/70) for the use of human samples. All animal work was 
approved by the institutional review board of Thomas Jefferson University.
The experimental design is summarised in Fig. 5. 
Human tissue. Human IVD tissue was obtained from patients undergoing microdiscectomy surgery for 
the treatment of nerve root compression as a result of IVD herniation or post-mortem (PM) examination with 
informed consent of the patients or relatives. Ethical approval was granted from Sheffield Research Ethics Com-
mittee (09/H1308/70).
Tissue processing. Human IVD tissue was fixed in 10% (v/v) neutral buffered formalin (Leica Microsys-
tems) and embedded into paraffin wax. Following embedding, 4 µm sections were cut and human IVDs his-
tologically graded using haematoxylin and eosin staining methods as described  previously57,58 to determine 
Figure 5.  Experimental design to investigate the in vitro osmotic regulation of AQP1 and 5 in NP cells and 
in vivo regulation of AQP1 and 5 by TonEBP in IVD tissue.
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severity of IVD degeneration. Samples were separated into individual groups according to grade of degenera-
tion: non-degenerate (grade 0–4), moderately-degenerate (grade 4.1–6.9) and severely-degenerate (grade 7–12).
Human NP cell extraction and culture. Human NP cells were isolated from surgical and PM tissue 
(Patient 1: Female, 55 years old, L5/S1, surgical, grade 5; Patient 2: Female, 31 years old, L4/L5, PM, grade 4; 
Patient 3, Male, 47 years old, L5/S1, surgical, grade 6.5) by digestion with 2 mg/mL collagenase type I (Life Tech-
nologies) for 4 h at 37 °C and filtered through a 40 µm cell strainer. Isolated NP cells were expanded in 2D culture 
using DMEM (Gibco) supplemented with 10% (v/v) FBS, 10,000 U/mL penicillin, 10 mg/mL streptomycin (P/S) 
(Gibco), 25 µg/mL amphotericin B (Sigma Aldrich), 2 mM l-glutamine (Gibco). Human NP cells at passage 2 
were utilised for all experiments.
Alginate culture. Following expansion up to passage 2, human NP cells were resuspended at a density of 
4 × 106 cells/mL in sterile filtered 1.2% (w/v) alginic acid (Sigma-Aldrich) in 0.15 M NaCl. Human NP cell-con-
taining alginate was polymerised by passing through a 20G needle into 0.2 M  CaCl2 drop-by-drop to produce 
alginate beads and left for 10 min to fully gel. Newly formed beads were washed with 0.15 M NaCl to remove 
excess  CaCl2 and washed twice with DMEM before standard culture media was added. Alginate beads were 
polymerised and cultured in 24-well plates with 6 beads per well. Alginate beads were cultured in standard con-
ditions for 2 weeks prior to treatment to allow human NP cells to differentiate into an in vivo-like  phenotype59.
Rat NP cell extraction and culture. Three Wistar rats (200-250 g) were euthanised with  CO2 and spinal 
columns dissected under aseptic conditions. Lumbar IVDs were separated from the spinal column and the NP 
separated from the AF using a dissecting microscope. NP tissue was partially digested with 0.1% (w/v) colla-
genase (Sigma-Aldrich) and 10U/mL hyaluronidase (Sigma-Aldrich) for 4-6 h and then maintained in DMEM 
supplemented with 10% (v/v) FBS and P/S. Rat NP cells migrated out of explant tissue after 1w; when confluent, 
cells were passaged using trypsin (0.25%) EDTA (1 mM), pooled together and subsequently cultured.
Hyperosmotic gene regulation of AQPs in human NP cells. Once expanded, human NP cells were 
seeded into 6-well plates in standard culture media. The osmolality of standard culture media is 325 mOsm/
kg and served as the untreated control condition in all experiments; this also mimics the native osmolality of a 
degenerate disc. Cells were treated with 425 mOsm/kg media for 8, 12, 24, 48 and 72 h to mimic the osmolality 
of the native, non-degenerate disc in monolayer (2D) culture. To alter the osmolality from 325 to 425 mOsm/
kg, 50 mM NaCl was added to media and the osmolality of all solutions was determined using a freezing point 
osmometer (Model 3320, Advanced Instruments). NP cells in 325 mOsm/kg media at 0 h time point were used 
as untreated controls. Following treatment, media was aspirated and 1 mL Trizol (Life Technologies) was added 
to lyse cells. Lysate was collected and 200 μL Chloroform (Sigma-Aldrich) added per mL Trizol (Life Technolo-
gies) to extract RNA. RNA was finally resuspended in 14μL RNase-free water (Qiagen, Manchester, UK) before 
proceeding to cDNA synthesis.
To explore how AQP gene expression was potentially altered by hyperosmotic stimulus in an environment 
mimicking the in vivo IVD conditions, as compared to 2D culture where NP cells are known to de-differentiate. 
Human NP cells were resuspended, cultured, and treated following encapsulation into alginate beads. Follow-
ing 2 weeks of culture in alginate beads to enable re-differentiation, alginate beads were treated (2 beads per 
well of a 96-well plate) with 325 mOsm/kg (mimicking degenerate conditions), 425 mOsm/kg or 525 mOsm/
kg (mimicking healthy conditions), produced by adding 50 mM or 100 mM NaCl added to standard culture 
media respectively, for 48 h. Human NP cells from 3 patients, each performed with technical triplicates, were 
used for both 2D and 3D hyperosmotic gene regulation experiments. Following treatment, beads were added to 
alginate dissolving buffer (55 mM sodium citrate, 30 mM EDTA, 0.15 M NaCl in  H2O) for 10 min at 37 °C on an 
orbital shaker before centrifugation at 300 g for 10 min. Supernatant was discarded and pellets resuspended in 
DMEM containing 0.4 mg/mL collagenase (Sigma-Aldrich) for 10 min at 37 °C on an orbital shaker to degrade 
extracellular matrix which had been deposited by NP cells during 3D culture. Samples were centrifuged for a 
further 10 min at 300 g, supernatant removed and 1 mL Trizol (Life Technologies) added to each sample. RNA 
was extracted using RNeasy mini kit (Qiagen) following the manufacturers guidelines. RNA was finally eluted 
from RNeasy mini kit columns with 14 μL RNase free water (Qiagen). RNA from both 2D and 3D alginate 
samples was synthesised into cDNA. qRT-PCR was utilised to identify regulation of gene expression of AQP1 
(Hs01033361_m1) and 5 (Hs00387048), employing pre-designed primer/probe mixes (Life Technologies).
Hyperosmotic gene regulation of AQPs in rat NP cells. Pooled NP cells from 3 rats were seeded 
at 3 × 104 cells/well in 6-well plates and treated with altered osmolality media (425 mOsm/kg or 525 mOsm/
kg) for 8 and 24 h. Experiments were performed in technical triplicates. NP cells cultured in standard media 
(325 mOsm/kg) at time point 0 h were used as controls. After treatment cells were washed in ice-cold PBS before 
cell lysis and RNA extraction. RNA was eluted in 20μL RNase-free water. Extracted RNA was then converted 
to cDNA by adding 20μL RNA to EcoDry premix (Takara) and incubated at 42 °C for 1 h, followed by 10 min 
at 70 °C. To determine regulation of AQP1 and 5 gene expression under hyperosmotic treatment qRT-PCR was 
performed for AQP1, 5 and GAPDH.
TonEBP knockdown in rat NP cells. To investigate the potential role of TonEBP in the hyperosmotic reg-
ulation of AQP1 and 5 in rat NP cells, the expression of this transcription factor was knocked down. HEK293T 
cells were seeded in 10 cm culture plates at 5 × 106 cells/plate in DMEM with 10% (v/v) heat inactivated FBS 24 h 
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prior to transfection. Cells were transfected with 9 μg shCTR (no knockdown control) or shTonEBP (TonEBP 
knockdown) plasmids along with 6 μg psPAX2 packaging plasmid and 3 μg pMD2.G VSV-G envelope express-
ing plasmid using Lipofectamine 2000 (Invitrogen). After 6 h transfection media was replaced with fresh DMEM 
with 10% (v/v) FBS. Lentiviral media was harvested at 48 h and 60 h post transfection and virus was precipitated 
by adding 7% PEG 6000 solution and storing at 4 °C for at least 12 h. Supernatant/PEG mixture was centrifuged 
at 1500 g for 30 min at 4 °C to pellet lentiviral particles. Rat NP cells were transduced with fresh media contain-
ing viral particles and 8 μg/mL polybrene (Sigma-Aldrich). Knockdown of TonEBP occurred for 5 days. On 
day 4, hyperosmotic media (425 mOsm/kg) was added to rat NP cells for 24 h of hyperosmotic treatment. Cells 
were harvested on day 5 of TonEBP knockdown and downstream experiments were performed to assess gene 
regulation of AQP1 and 5 as described above. Pooled NP cells from 3 rats (in technical triplicates) were used in 
these experiments.
TonEBP −/− mice. Nfat5 mutant mice on C57BL/6 background were kindly provided by H. Moo Kwan 
from the Ulsan National Institute of Science and  Technology60. Genotyping of Nfat5 mice and embryos was per-
formed by PCR as described  previously60. The mice were bred socially using aseptic technique with barrier con-
ditions and fed Lab Diet 5010 Laboratory Autoclavable Rodent ad libitum. The litters were of normal size (rang-
ing from 3 to 12) and the embryos were distributed into control and experimental groups based on genotype 
(wildtype vs −/−). Therefore, it was assumed that the distribution of sex was even between the groups, although 
this was not objectively determined and cannot be retrospectively confirmed. After sacrifice at E17.5, the spines 
were dissected and immediately fixed in 4% PFA for 2 days at 4 °C. The spines were subsequently decalcified in 
20% EDTA for 3 days at 4 °C and then embedded in paraffin by the Thomas Jefferson University histopathology 
core facility. All animal procedures were conducted under the guidelines of the Institutional Animal Care and 
Use Committee of Thomas Jefferson  University21.
Immunohistochemistry. Seven-micron sagittal sections were de-paraffinized in histoclear and rehydrated 
in a series of ethanol solutions (100%-70%). De-paraffinized sections were treated with Proteinase K (1:500) for 
10 min at room temperature. The sections were then incubated for 1 h in 5% Normal Goat Serum and subse-
quently incubated overnight at 4 °C with primary antibody against aquaporin 1 (1:100; abcam, ab168387) and 
aquaporin 5 (1:100; Millipore, Sigma-Aldrich, A4979). After washing with PBS, sections were incubated for 
1 h at room temperature with either Alexa Fluor-594 or Alexa Fluor-647 secondary antibodies (1:700, Jackson 
ImmunoResearch Lab, Inc.). The sections were washed with PBS before mounting with ProLong Gold Anti-
fade Mountant containing DAPI (Thermo Fisher Scientific, P36934), and visualized by fluorescence microscopy 
(Axio Imager 2, Zeiss, White Plains, USA) using the 20×/0.5 EC Plan-Neofluar (Zeiss) objective. The stained sec-
tions were imaged using X-Cite 120Q Excitation Light Source (Excelitas, Waltham, USA), the AxioCam MRm 
camera (Zeiss), and Zen2 software (Zeiss). Staining of mouse embryos was performed on five embryos per group 
(wildtype/NFAT5 null), with at least three representative discs per embryo analysed.
Digital image analysis. Imaged sections stained by immunohistochemistry were analysed using ImageJ 
1.52a61 in grayscale. The boundaries of NP cells were digitally traced using the Freehand Tool and the all images 
were set to the same threshold to create binary images. Designated regions of interest were analysed using the 
area fraction measurement for each section.
Statistical analysis. The regulation of AQP1 and 5 gene expression, in both human and rat NP cells, was 
performed in triplicate on 3 patients/pooled rat cells on different days. Data was found to be non-parametric, 
therefore Kruskall-Wallis with Dwass-Steel-Critchlow-Fligner post hoc analysis test (Stats Direct) was used to 
identify significant differences between AQP1 and 5 gene expression. Data from digital image analysis of IHC 
staining was found to be non-parametric, therefore Kruskall-Wallis with Dwass-Steel-Critchlow-Fligner post 
hoc analysis test was used to identify significant differences between fluorescent intensities of WT and TonEBP 
−/− mice, after AQP1 and 5 IHC experiments, to determine putative changes in expression.
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